Drug Shortage Report for NOREPINEPHRINE BITARTRATE INJECTION USP

Last updated on 2022-10-13 History
Report ID 159100
Drug Identification Number 00893285
Brand name NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
Common or Proper name NOREPINEPHRINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) NOREPINEPHRINE
Strength(s) 1MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4ML 10LIV
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-09-27
Estimated end date 2022-10-21
Actual end date 2022-10-12
Shortage status Resolved
Updated date 2022-10-13
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2022-10-13 English Compare
v23 2022-10-12 French Compare
v22 2022-10-12 English Compare
v21 2022-10-04 French Compare
v20 2022-10-04 English Compare
v19 2022-09-28 English Compare
v18 2022-09-27 French Compare
v17 2022-09-27 English Compare
v16 2022-09-13 French Compare
v15 2022-09-13 English Compare
v14 2022-09-13 English Compare
v13 2022-09-06 French Compare
v12 2022-08-19 French Compare
v11 2022-08-19 English Compare
v10 2022-08-19 French Compare
v9 2022-08-19 English Compare
v8 2022-08-19 English Compare
v7 2022-06-17 French Compare
v6 2022-06-17 English Compare
v5 2022-06-04 English Compare

Showing 1 to 20 of 24